Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance · Sep 1, 2026 · AnaptysBio Inc (ANAB)
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today announced that Chris Murphy, chief financial officer, is scheduled to present at the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, Sept. 15, 2026. The presentation is scheduled to begin at 3:30pm ET. A live webcast of the presentation will be available on the investor section of the
Not investment advice. Cached headline, not a full reprint.